Skip to main content
Clinical Trials/NCT05973929
NCT05973929
Recruiting
N/A

Clinical and Radiological Evaluation of Movement Disorders in Multiple Sclerosis Patients.

Al-Azhar University1 site in 1 country57 target enrollmentSeptember 22, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Al-Azhar University
Enrollment
57
Locations
1
Primary Endpoint
Determine the prevalence of movement disorders in MS patients.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to determine the prevalence of movement disorders in MS patients.

Also,To know the clinical type of movement disorders occurring with multiple sclerosis patients and the MRI finding of those patients. Moreover, to find the correlation between the movement disorder and the different types of MS.

Detailed Description

A randomized cross-sectional study will be conducted on diagnosed multiple sclerosis patients who were diagnosed according to McDonald criteria of MS 2017 (Thompson et al. 2018). The investigators will study the prevalence of movement disorders in M.S patients, clinical type of movement disorder and the MRI findings. Data collected from patients admitted or following at Al-Azhar university hospitals at Al-Hussein and El-Sayed Galal hospitals. The included eligible patients should fulfil the following inclusion criteria: i. Full clinical history and neurological assessment. ii. Detailed multiple sclerosis history according to MS unit history sheet. iii. Detailed history of movement disorder which include clinical type of movement disorder and medication taken (or not). iv. MRI Brain and spine of the included patient will be photographed. Exclusion criteria: 1. Patients with multiple sclerosis mimics which can cause movement disorders e.g., systemic disease or overlap syndromes including systemic lupus, vasculitis, hepatic failure, renal failure, hyperthyroidism, electrolyte disturbances, Behcet's disease or CNS infection. 2. patients with primary movement disorders or related to other neurodegenerative diseases.

Registry
clinicaltrials.gov
Start Date
September 22, 2022
End Date
May 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mostafa Mahmoud Hassan Meshref

Neurology physician

Al-Azhar University

Eligibility Criteria

Inclusion Criteria

  • We will study the prevalence of movement disorders in M.S patients, clinical type of movement disorder and the MRI findings. Data collected from patients admitted or following at Al-Azhar university hospitals at Al-Hussein and El-Sayed Galal hospitals. The included eligible patients should fulfil the following inclusion criteria: i. Full clinical history and neurological assessment. ii. Detailed multiple sclerosis history according to MS unit history sheet. iii. Detailed history of movement disorder which include clinical type of movement disorder and medication taken (or not).
  • iv. MRI Brain and spine of the included patient will be photographed.

Exclusion Criteria

  • 1-Patients with multiple sclerosis mimics which can cause movement disorders e.g., systemic disease or overlap syndromes including systemic lupus, vasculitis, hepatic failure, renal failure, hyperthyroidism, electrolyte disturbances, Behcet's disease or CNS infection.
  • 2-patients with primary movement disorders or related to other neurodegenerative diseases.

Outcomes

Primary Outcomes

Determine the prevalence of movement disorders in MS patients.

Time Frame: Through study completion, an average of 1.5 year

To know the percentage of occurance of movement disorders in MS patients.

find the correlation between the movement disorder and the different types of MS.

Time Frame: Through study completion, an average of 1.5 year

To know if there is a correlation between the movement disorder and the different types of MS.

know the clinical type of movement disorders occurring with multiple sclerosis patients and the MRI finding of those patients.

Time Frame: Through study completion, an average of 1.5 year

To know the specific semiology for each movement disorder.

Study Sites (1)

Loading locations...

Similar Trials